{
  "id": 17810361,
  "title": "Keytruda biosimilars are coming — but they face an uphill battle",
  "url": "https://urgent.news/2026/11/02/keytruda-biosimilars-are-coming-but-they-face-an-uphill-battle",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-02T14:34:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/keytruda-biosimilars-fda-pbm-market-share-drug/873424/"
  },
  "original_language": "en",
  "account": null,
  "summary": "A patent cliff is fast approaching for Merck’s flagship blockbuster, but the deck might be stacked against its biosimilars gaining widespread traction.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}